CureVac Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $12 to $4
在Leerink Partners将该股的评级从跑赢大盘下调至市场表现并将其目标股价从12美元下调至4美元之后,CureVac股价走低
CureVac Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $12 to $4
在Leerink Partners将该股的评级从跑赢大盘下调至市场表现并将其目标股价从12美元下调至4美元之后,CureVac股价走低
使用浏览器的分享功能,分享给你的好友吧